Monoclonal Mouse anti‑Human C4orf36 Antibody (clone OTI8B7, Carrier‑free, IHC, WB) LS‑C791558
Monoclonal Mouse anti‑Human C4orf36 Antibody (clone OTI8B7, Carrier‑free, IHC, WB) LS‑C791558
Antibody:
C4orf36 Mouse anti-Human Monoclonal (Carrier-free) (OTI8B7) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
C4orf36 Mouse anti-Human Monoclonal (Carrier-free) (OTI8B7) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
C4orf36 antibody LS-C791558 is an unconjugated mouse monoclonal antibody to human C4orf36. Validated for IHC and WB.
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Full length human recombinant protein of human C4orf36(NP_653246) produced in E.coli.
Applications
- IHC (1:150)
- Western blot (1:2000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Source:
Human
Tag:
Myc-DDK (Flag)
Source:
Human
Tag:
Myc-DDK (Flag)
Species:
Human
Applications:
Immunodiffusion
Reactivity:
Range:
4.94-400 pg/ml
Reactivity:
Mouse
Range:
3.12-200 pg/ml
Reactivity:
Mouse
Range:
7.8-500 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 6/27/2024